Naphthoylindoles

From WikiMD's WELLNESSPEDIA


Chemical structure of JWH-018, a naphthoylindole.

Naphthoylindoles are a class of synthetic cannabinoids that act on the cannabinoid receptors in the brain. These compounds are structurally related to the naturally occurring cannabinoids found in the Cannabis plant but are designed to mimic their effects. Naphthoylindoles are often used in the production of synthetic cannabis products, commonly known as "spice" or "K2."

Chemical Structure[edit]

Naphthoylindoles are characterized by the presence of a naphthoyl group attached to an indole core. The general structure consists of a naphthalene ring system linked to an indole moiety, which is a bicyclic structure containing a benzene ring fused to a pyrrole ring. The chemical structure of JWH-018, one of the most well-known naphthoylindoles, is depicted in the image.

Pharmacology[edit]

Naphthoylindoles function as agonists at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation. The binding of naphthoylindoles to these receptors can produce effects similar to those of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.

Usage and Effects[edit]

Naphthoylindoles are primarily used in the formulation of synthetic cannabis products. These products are often marketed as legal alternatives to cannabis, although their legal status varies by jurisdiction. The effects of naphthoylindoles can include euphoria, relaxation, altered perception, and, in some cases, anxiety or paranoia. Due to their potency and variability, the use of synthetic cannabinoids can pose significant health risks.

Legal Status[edit]

The legal status of naphthoylindoles varies worldwide. Many countries have moved to ban or regulate these substances due to their potential for abuse and adverse health effects. In the United States, several naphthoylindoles, including JWH-018, are classified as Schedule I controlled substances, indicating a high potential for abuse and no accepted medical use.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.